3
Revista Matronas

Revista Matronas

SEPTIEMBRE 2023 N° 2 Volumen 11

Quality of life in persons with uterus who are low-risk carriers of HPV in the Valparaíso region, year 2022

Section: Originales

How to quote

Calderón Canales F, Bravo Rojo FC, Gómez Molina IV, González Cepeda PJI, González Miranda JV, Jara Zamora JA, et al. Calidad de vida en personas con útero portadoras de VPH de bajo riesgo en la región de Valparaíso, año 2022. Matronas Hoy 2023; 11(2):6-15.

Authors

1 Felipe Calderón Canales, 2 Francisca Carolina Bravo Rojo, 2 Isadora Valentina Gómez Molina, 2 Paula Javiera Isidora González Cepeda, 2 Javiera Francisca González Miranda, 2 Javiera Antonia Jara Zamora, 2 Camila Ivette Jojot Torrecilla, 2 Fiorella Clodhet Marchant Muñoz

Position

1 Magíster en Salud Pública. Académico carrera de Obstetricia. Facultad de Medicina Universidad Andrés Bello. Viña del Mar (Chile).2 Licenciado/a en Obstetricia (Matrón/a). Facultad de Medicina. Universidad Andrés Bello. Viña del Mar (Chile).

Contact email: felipe.calderon.canales@gmail.com

Abstract

Quality of life in persons with uterus who are low-risk carriers of HPV in the Valparaíso region, year 2022
Introduction: condyloma is a sexually transmitted disease (STD) caused by the human papilloma virus (HPV) with low risk. It is characterized by the presence of genital warts mostly in the perianal area, though not exclusively, which can alter different aspects of the quality of life of those persons affected. For this reason, it is considered relevant to analyse the disease from a biopsychosocial perspective, including lifestyle and changes faced, through an assessment of the level of discomfort caused by the clinical signs experienced, and the main aspects of life affected by these.
Objective: to analyse the quality of life of persons with uterus who were diagnosed with low risk HPV within the last three years in the Valparaíso Region (Chile).
Materials and methods: a descriptive cross-sectional quantitative study. A survey with 21 dichotomous closed questions was applied to persons with uterus diagnosed with HPV, who had presented condyloma during the period of the last three years, with ages between 18 and 40 years, Chilean nationality, and residence in the Valparaíso Region.
Results: a great proportion of asymptomatic women with presence of genital warts was observed, as well as a high validity of Papanicolaou (PAP) tests and efficacy in treatments, a high proportion in care within the private system, and also a low quality of life at the time of diagnosis, but with improvement after receiving treatment.
Conclusion: the most determining factors at the time of treatment were its efficacy, knowledge about the condition and its risks, and awareness of the importance of monitoring and the PAP / smear test.

Keywords:

STD; HPV; condyloma; quality of lifemidwives

Versión en Español

Título:

Calidad de vida en personas con útero portadoras de VPH de bajo riesgo en la región de Valparaíso, año 2022

Artículo completo no disponible en este idioma / Full article is not available in this language

Bibliography

  1. MINSAL/DIPRECE. Infecciones de Transmisión Sexual. MISAL/DIPRECE [internet] 2019 [citado 12 jul 2023]. Disponible en: https://diprece.minsal.cl/temas-de-salud/orden-alfabetico/condilima-acumulado
  2. Carvajal J, Barriga MI. Manual de Obstetricia y Ginecología. Edición XIII. Santiago, Chile: Editorial UC; 2022.
  3. Greer CE, Wheeler CM, Ladner MB. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol [internet] 1995 [citado 12 jul 2023]; 33:2058. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC228335/
  4. Brown DR, Schroeder JM, Bryan JT. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol [internet] 1999 [citado 12 jul 2023]; 37:3316. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC85555/
  5. Aubin F, Prétet JL, Jacquard AC. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis [internet] 2008 [citado 12 jul 2023]; 47:610. Disponible en: https://academic.oup.com/cid/article/47/5/610/295268?login=false
  6. MINSAL/DIPRECE. Departamento Programa Nacional de Prevención y Control VIH/SIDA e ITS del Ministerio de Salud. Norma de Profilaxis, Diagnóstico y Tratamiento de las Infecciones de Transmisión Sexual (ITS) [internet]. Santiago, Chile: MISAL/DIPRECE; 2016 [citado 12 jul 2023]. Disponible en: https://diprece.minsal.cl/wrdprss_minsal/wp-content/uploads/2014/11/NORMA-GRAL.-TECNICA-N%C2%B0-187-DE-PROFILAXIS-DIAGNOSTICO-Y-TRATAMIENTO-DE-LAS-ITS.pdf
  7. WHO Quality of Life Assessment Group. (1996). ¿Qué calidad de vida? Foro mundial de la salud. WHO [internet] 1996 [citado 12 jul 2023]; 17(4):385-7. Disponible en: https://apps.who.int/iris/handle/10665/55264
  8. WHO/HIS/HIS. Programme on Mental Health. WHOQOLD. Division of Mental health and prevention of substance abuse [internet]. Geneva: WHO; 2012 [citado 12 jul 2023]. Disponible en:  https://www.who.int/publications/i/item/WHO-HIS-HSI-Rev.2012.03
  9. MINSAL, OPS; OMS. MINSAL y OPS/OMS Chile refuerzan importancia de vacunación contra el Virus Papiloma Humano. OMS [internet] 2021 [citado 12 jul 2023]. Disponible en: https://www.paho.org/es/noticias/10-11-2021-minsal-opsoms-chile-refuerzan-importancia-vacunacion-contra-virus-
  10. Sendagorta-Cudós J, Rodríguez-Iglesias M. Infecciones genitales por el virus del papiloma humano. Enfermedades Infecciosas y Microbiología clínica. [internet] 2019 [citado 12 jul 2023]; 37(5):324-34. Disponible en: https://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-articulo-infecciones-genitales-por-el-virus-S0213005X19301223
  11. Ministerio de Salud. Guías Clínicas AUGE. Cáncer cérvico-uterino. MINSAL [internet] 2015 [citado 12 jul 2023]. Disponible en: https://www.minsal.cl/wp-content/uploads/2015/09/GPC-CaCU.pdf
  12. National Cancer Institute. HPV and Pap Test Results: Next Steps after an Abnormal Cervical Cancer Screening Test. National Cancer Institute [internet] 2023  [citado 12 jul 2023]. Disponible en: https://www.cancer.gov/types/cervical/screening/abnormal-hpv-pap-test-results
  13. Instituto de Salud Pública. Ministerio de Salud Pública de Chile. Vigilancia HPV. Ministerio de Salud Pública de Chile [internet] 2020 [citado 12 jul 2023]. Disponible en: https://www.ispch.gob.cl/biomedico/vigilancia-de-laboratorio/ambitos-de-vigilancia/vigilancia-hpv/
  14. Instituto de Salud Pública, MINSAL. Virus del Papiloma Humano-PCR. Ministerio de Salud Pública de Chile [internet] 2022 [citado 12 jul 2023]. Disponible en: https://www.ispch.gob.cl/prestacion/2155047/
  15. De Sanjose WC, Quint L, Alemany DT, Geraets JE, Klaustermeier B. Lloveras, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol [internet] 2010 [citado 12 jul 2023]; 11:1048-56. Disponible en: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(10)70230-8/fulltext
  16. Schiffman N, Wentzensen S, Wacholder W. Kinney JC, Gage PE. Castle Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst [internet] 2011 [citado 12 jul 2023]; 103:368-83. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046952/
  17. Ferreccio C. Nuevas estrategias de prevención y control de cáncer de cuello uterino en Chile. Salud Pública Mex [internet] 2018 [citado 12 jul 2023]; 60(6,v-dic):713. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342018000600015
  18. MINSAL. Normas de manejo y tratamiento de infecciones de transmisión sexual (ITS) [internet]. Santiago, Chile: Ministerio de Salud; 2008 [citado 12 jul 2023]. Disponible en:  https://icmer.org/wp-content/uploads/2019/Infecciones_de_transmisi%C3%B3n_sexual/Normas-ITS-FINAL.pdf
  19. Silva R, León D, Brebi P, Ili C, Roa JC, Sánchez R. Diagnóstico de la infección por virus papiloma humano en el hombre. Rev. chil. infectol. 2013 Abr; 30(2):186-92. Doi: https://dx.doi.org/10.4067/S0716-10182013000200009
  20. De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol [internet] 2008 [citado 12 jul 2023]; 13(6):607-15. Disponible en: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(12)70137-7/fulltext